Holder’s Option. (a) Each Holder agrees to either: (i) exchange all Series C Warrants for shares of the Company’s common stock, on the basis of one (1) share of common stock (“Exchange Shares”) for every two (2) shares of the Company’s common stock purchasable by such Holder pursuant to the Series C Warrants (the “Securities Exchange Option”). No fractional shares shall be issued in exchange for the Series C Warrants; or (ii) exercise all of its respective Series C Warrants to purchase the Company’s common stock (the “Exercise Shares”) at a reduced exercise price of $0.10 per Warrant Share (the “Warrant Exercise Option”). The Exchange Shares and the Warrant Shares are sometimes herein referred to as the “Securities.” (b) Each Holder shall make its election as to which option it wishes to exercise on the signature page hereto.
Appears in 2 contracts
Sources: Warrant Exercise or Exchange Agreement (Hepalife Technologies Inc), Warrant Exercise or Exchange Agreement (Hepalife Technologies Inc)